- 专利标题: CULTURE MEDIUM FOR LUNG CANCER EPITHELIAL CELLS, CULTURE METHOD, AND APPLICATION THEREOF
-
申请号: US18577457申请日: 2021-07-28
-
公开(公告)号: US20240344020A1公开(公告)日: 2024-10-17
- 发明人: Qingsong LIU , Jie HU , Tao HUANG , Cheng CHEN
- 申请人: PRECEDO PHARMACEUTICALS CO., LTD
- 申请人地址: CN Hefei, Anhui
- 专利权人: PRECEDO PHARMACEUTICALS CO., LTD
- 当前专利权人: PRECEDO PHARMACEUTICALS CO., LTD
- 当前专利权人地址: CN Hefei, Anhui
- 优先权: CN 2110773847.3 2021.07.08
- 国际申请: PCT/CN2021/108807 2021.07.28
- 进入国家日期: 2024-01-08
- 主分类号: C12N5/00
- IPC分类号: C12N5/00 ; C12N5/09
摘要:
A primary cell culture medium for culturing primary lung cancer epithelial cells, containing an MST1/2 kinase inhibitor, a ROCK inhibitor, fibroblast growth factor 7, at least one additive of B27 additive and N2 additive, hepatocyte growth factor, insulin-like growth factor 1, interleukin 6, and a TGFβ type I receptor inhibitor. The invention also relates to a culture method using the primary cell culture medium and its application in the efficacy evaluating and screening of drugs. In the culture method, the primary cell culture medium is used to culture primary cells in a culture vessel coated with an extracellular matrix gel, to make the primary cells expend rapidly. A cell model obtained using the primary cell culture medium and the primary cell culture method can be used for the efficacy evaluating and screening of drugs.
信息查询